Dermatol. praxi. 2023;17(1):8-12 | DOI: 10.36290/der.2023.001

Care for children with epidermolysis bullosa

Mgr. Petra Šimánková
Slezská univerzita v Opavě, Fakulta veřejných politik, Ústav nelékařských zdravotnických studií, Opava

Children with epidermolysis bullosa (EB) are a rare population with high morbidity and mortality. EB has a profound impact on the daily life of the patient and family members, on the child's physical, psychological and mental health, including disruption of social relationships. It is common for EB patients to be cared for by health professionals who are not specialized in this rare disorder. Health professionals educate parents about safety and preventive steps in caring for a child with EB, how to treat the child, how to recognize the characteristics of a wound, how to care for wounds, how to breastfeed and feed the child, etc. Increasing the knowledge of all healthcare professionals on EB issues, including age at clinical diagnosis and severe clinical signs, will support the optimisation of healthcare and nursing practices and contribute to improving the quality of life of paediatric patients with EB.

Keywords: epidermolysis bullosa, children, prognosis, complications, nursing care.

Accepted: March 23, 2023; Published: March 28, 2023  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Šimánková P. Care for children with epidermolysis bullosa. Dermatol. praxi. 2023;17(1):8-12. doi: 10.36290/der.2023.001.
Download citation

References

  1. Ott Hc, Eich C, Schriek K, Ludwikowski B. Epidermolysis bullosa hereditaria bei Schulkindern und Adoleszenten. Der Hautarzt [Internet]. 2016;67(4):279-286 [cited 2022-08-21]. ISSN 0017-8470. Available from: doi:10.1007/s00105-016-3774-6. Go to original source... Go to PubMed...
  2. Retrosi Ch, Diociaiuti A, Ranieri C, et al. Multidisciplinary care for patients with epidermolysis bullosa from birth to adolescence: experience of one Italian reference center. Italian Journal of Pediatrics [Internet]. 2022;48(1) [cit. 2022-09-11]. ISSN 1824-7288. Available from: doi:10.1186/s13052-022-01252-3. Go to original source... Go to PubMed...
  3. Has C, El Hachem M, Bučková H, et al. Practical management of epidermolysis bullosa: consensus clinical position statement from the European Reference Network for Rare Skin Diseases. Journal of the European Academy of Dermatology and Venereology [Internet]. 2021;35(12):2349-2360 [cit. 2022-08-24]. ISSN 0926-9959. Available from: doi:10.1111/jdv.17629 Go to original source... Go to PubMed...
  4. Ganani D, Malovitski K, Sarig O, et al. Epidermolysis bullosa simplex due to bi-allelic DST mutations: Case series and review of the literature. Pediatric Dermatology [Internet]. 2021; 38(2):436-441 [cit. 2022-08-21]. ISSN 0736-8046. Available from: doi:10.1111/pde.14477 Go to original source... Go to PubMed...
  5. Huitema L, Phillips T, Alexeev V, et al. Immunological mechanisms underlying progression of chronic wounds in recessive dystrophic epidermolysis bullosa. Experimental Dermatology [Internet]. 2021;30(12):1724-1733 [cit. 2022-08-21]. ISSN 0906-6705. Available from: doi:10.1111/exd.14411. Go to original source... Go to PubMed...
  6. Marchili Mr, Spina G, Roversi M, et al. Epidermolysis Bullosa in children: the central role of the pediatrician. Orphanet Journal of Rare Diseases [Internet]. 2022;17(1) [cit. 2022-08-22]. ISSN 1750-1172. Available from: doi:10.1186/s13023-021-02144-1 Go to original source... Go to PubMed...
  7. Baardman R, Yenamandra VK, Duipmans JC, et al. Novel insights into the epidemiology of epidermolysis bullosa (EB) from the Dutch EB Registry: EB more common than previously assumed? Journal of the European Academy of Dermatology and Venereology [Internet]. 2021;35(4):995-1006 [cit. 2022-08-22]. ISSN 0926-9959. Available from: doi:10.1111/jdv.17012. Go to original source... Go to PubMed...
  8. Pongmee P, Wittayakornrerk S, Lekwuttikarn R, et al. Epidermolysis Bullosa With Congenital Absence of Skin: Congenital Corneal Cloudiness and Esophagogastric Obstruction Including Extended Genotypic Spectrum of PLEC, LAMC2, ITGB4 and COL7A1. Frontiers in Genetics [online]. 2022;13 [cit. 2022-08-21]. ISSN 1664-8021. Dostupné z: doi:10.3389/fgene.2022.847150. Go to original source... Go to PubMed...
  9. Lalor L, Titeux M, Palisson F, et al. Epidermolysis bullosa simplex-generalized severe type due to keratin 5 p.Glu477Lys mutation: Genotype-phenotype correlation and in silico modeling analysis. Pediatric Dermatology [online]. 2019; 36(1):132-138 [cit. 2022-08-21]. ISSN 0736-8046. Dostupné z: doi:10.1111/pde.13722- Go to original source... Go to PubMed...
  10. Korolenkova MV, Poberezhnaya A, Yu L. Dental age in children with epidermolysis bullosa. Stomatologiya [online]. 2021;100(4) [cit. 2022-08-21]. ISSN 0039-1735. Dostupné z: doi:10.17116/stomat202110004168. Go to original source... Go to PubMed...
  11. Sari S, Kaya I, Demirel A. Oral precancerous lesions in childhood: Attention pediatricians and pediatric dentists/Cocuklarda Oral Prekanseroz Lezyonlar: Pediatrician and Pedodontistlerin Dikkatine. Meandros Medical and Dental Journal. 2019;20(2):98-106. Go to original source...
  12. Nedelcuţă R, Călin G, Nedelcuţă, et al. Collagen-based biomaterials with possible therapeutic effects. Journal of Mind and Medical Sciences [online]. 2021;324-329 [cit. 2022-08-28]. ISSN 23927674. Dostupné z: doi:10.22543/7674.82.P324329. Go to original source...
  13. Krämer S, Lucas J, Gamboa F, et al. Clinical practice guidelines: Oral health care for children and adults living with epidermolysis bullosa. Special Care in Dentistry [online]. 2020;40(S1):3-81 [cit. 2022-09-12]. ISSN 0275-1879. Dostupné z: doi:10.1111/scd.12511. Go to original source... Go to PubMed...
  14. Sawka E, Funk T. Dominant dystrophic epidermolysis bullosa with congenital absence of skin and brachydactyly of the great toes. Pediatric Dermatology [online]. 2021;38(5): 1251-1254 [cit. 2022-08-27]. ISSN 0736-8046. Dostupné z: doi:10.1111/pde.14727. Go to original source... Go to PubMed...
  15. Chen D, Zuckerman S, Akerman Y, et al. A new prenatal sonographic sign of epidermolysis bullosa. Journal of Clinical Ultrasound [online]. 2021;49(1):59-61 [cit. 2022-08-27]. ISSN 0091-2751. Dostupné z: doi:10.1002/jcu.22922. Go to original source... Go to PubMed...
  16. Štublar A, Dragoš V, Dolenc-Voljč M. Inherited epidermolysis bullosa: epidemiology and patient care in Slovenia with a review of the updated classification. Acta Dermatovenerol Alp Pannonica Adriat. 2021;30(2):63-66. Go to original source... Go to PubMed...
  17. Wang JY, Marinkovich MP, Rieger KE. Epidermolysis bullosa with pyloric atresia consistently demonstrates concurrent low intra-basal epidermal and lamina lucida cleavage planes: a survey of six cases. Journal of the European Academy of Dermatology and Venereology [online]. 2020;34(4) [cit. 2022-08-27]. ISSN 0926-9959. Dostupné z: doi:10.1111/jdv.16153. Go to original source... Go to PubMed...
  18. Mellerio J, El Hachem EM, Bellon N, et al. Emergency management in epidermolysis bullosa: consensus clinical recommendations from the European reference network for rare skin diseases. Orphanet Journal of Rare Diseases [online]. 2020;15(1) [cit. 2022-08-22]. ISSN 1750-1172. Dostupné z: doi:10.1186/s13023-020-01403-x. Go to original source... Go to PubMed...
  19. Chong SCH, Hon Kl, Yuen L, et al. Neonatal epidermolysis bullosa: lessons to learn about genetic counseling. Journal of Dermatological Treatment [online]. 2021;32(1):29-32 [cit. 2022-08-21]. ISSN 0954-6634. Dostupné z: doi:10.1080/09546634.2018.1527999. Go to original source... Go to PubMed...
  20. Khan MT, O'sullivan M, Faitli B, et al. Foot care in epidermolysis bullosa: evidence-based guideline. British Journal of Dermatology [online]. 2020;182(3):593-604 [cit. 2022-10-19]. ISSN 0007-0963. Dostupné z: doi:10.1111/bjd.18381. Go to original source... Go to PubMed...
  21. Phillips T, Huitema L, Cepeda R, et al. Aberrant recruitment of leukocytes defines poor wound healing in patients with recessive dystrophic epidermolysis bullosa. Journal of Dermatological Science [online]. 2020;100(3):209-216 [cit. 2022-08-21]. ISSN 09231811. Dostupné z: doi: 10.1016/j.jdermsci.2020.10.009. Go to original source... Go to PubMed...
  22. Zhou A, Little A, Antaya R. Epidermolysis bullosa pruriginosa treated with dupilumab. Pediatric Dermatology [online]. 2021;38(2):526-527 [cit. 2022-10-16]. ISSN 0736-8046. Dostupné z: doi:10.1111/pde.14493. Go to original source... Go to PubMed...
  23. Chan J, Weisman MA, King A, et al. Occupational therapy for epidermolysis bullosa: clinical practice guidelines. Orphanet Journal of Rare Diseases [online]. 2019;14(1) [cit. 2022-08-25]. ISSN 1750-1172. Dostupné z: doi:10.1186/s13023-019-1059-8. Go to original source... Go to PubMed...
  24. Stevens LI, Mckenna JS, Marty J, et al. Understanding the outcomes of a home nursing programme for patients with epidermolysis bullosa: an Australian perspective. International Wound Journal [online]. 2016;13(5):863-869 [cit. 2022-08-25]. ISSN 17424801. Dostupné z: doi:10.1111/iwj.12394. Go to original source... Go to PubMed...
  25. Martinez-Moreno A, Ocampo-Candiani J, Alba-Rojas E. Epidermolysis bullosa with congenital absence of skin: Review of the literature. Pediatric Dermatology [online]. 2020;37(5):821-826 [cit. 2022-08-27]. ISSN 0736-8046. Dostupné z: doi:10.1111/pde.14245. Go to original source... Go to PubMed...
  26. Sathishkumar D, Jacob AR. Learning to pop blisters in epidermolysis bullosa with a simple model. Pediatric Dermatology [online]. 2020;37(6):1215-1217 [cit. 2022-08-27]. ISSN 0736-8046. Dostupné z: doi:10.1111/pde.14379. Go to original source... Go to PubMed...
  27. Li Aw, Prindaville B, Bateman S, et al. Inpatient management of children with recessive dystrophic epidermolysis bullosa: A review. Pediatric Dermatology [online]. 2017; 34(6):647-655 [cit. 2022-08-22]. ISSN 07368046. Dostupné z: doi:10.1111/pde.13276. Go to original source... Go to PubMed...
  28. Guttmann-Gruber Ch, Piñón Hofbauer J, Tockner B, et al. Impact of low-dose calcipotriol ointment on wound healing, pruritus and pain in patients with dystrophic epidermolysis bullosa: A randomized, double-blind, placebo-controlled trial. Orphanet Journal of Rare Diseases [online]. 2021; 16(1) [cit. 2022-10-16]. ISSN 1750-1172. Dostupné z: doi:10.1186/s13023-021-02062-2. Go to original source... Go to PubMed...
  29. Papanikolaou M, Onoufriadis A, Mellerio JE, et al. Prevalence, pathophysiology and management of itch in epidermolysis bullosa. British Journal of Dermatology [online]. 2021;184(5):816-825 [cit. 2022-10-16]. ISSN 0007-0963. Dostupné z: doi:10.1111/bjd.19496. Go to original source... Go to PubMed...
  30. Hartenstein-Pinter A, Hübner-Möhler B, Zernikow B, et al. Verbandsmaterial bei Kindern mit Epidermolysis bullosa. Der Schmerz [online]. 2020;34(2):156-165 [cit. 2022-08-27]. ISSN 0932. Dostupné z: doi:10.1007/s00482-019-00439-8. Go to original source... Go to PubMed...
  31. Cohn H, Teng J. Advancement in management of epidermolysis bullosa. Current Opinion in Pediatrics [online]. 2016;28(4):507-516 [cit. 2022-08-28]. ISSN 1040-8703. Dostupné z: doi:10.1097/MOP.0000000000000380. Go to original source... Go to PubMed...
  32. Cianfarani F, Zambruno G, Astiglia D, et al. Pathomechanisms of Altered Wound Healing in Recessive Dystrophic Epidermolysis Bullosa. The American Journal of Pathology [online]. 2017;187(7):1445-1453 [cit. 2022-08-21]. ISSN 00029440. Dostupné z: doi: 10.1016/j.ajpath.2017.03.003. Go to original source... Go to PubMed...
  33. Nyström A, Bruckner-Tuderman L. Injury - and inflammation-driven skin fibrosis: The paradigm of epidermolysis bullosa. Matrix Biology [online]. 2018;68-69:547-560 [cit. 2022-08-21]. ISSN 0945053X. Dostupné z: doi: 10.1016/j.matbio.2018.01.016. Go to original source... Go to PubMed...
  34. Suresh S, Ecoffey C, Bosenberg A, et al. European Society of Regional Anaesthesia and Pain Therapy/American Society of Regional Anesthesia and Pain Medicine Recommendations on Local Anesthetics and Adjuvants Dosage in Pediatric Regional Anesthesia. Regional Anesthesia and Pain Medicine [online]. 2018 [cit. 2022-08-25]. ISSN 1098-7339. Dostupné z: doi:10.1097/AAP.0000000000000702. Go to original source... Go to PubMed...
  35. Chambelland A, Devos C, Casagrande F, et al. Topical ropivacaine for analgesia of aplasia cutis congenita in newborns with hereditary epidermolysis bullosa. Orphanet Journal of Rare Diseases [online]. 2020;15(1) [cit. 2022-08-25]. ISSN 1750-1172. Dostupné z: doi:10.1186/s13023-020-01605-3. Go to original source... Go to PubMed...
  36. Moreno-Artero E, Schinkel N, Chaumon S, et al. Efficacy of topical ropivacaine in children and young adults with hereditary epidermolysis bullosa. British Journal of Dermatology [online]. 2021;184(3):550-552 [cit. 2022-08-22]. ISSN 0007-0963. Dostupné z: doi:10.1111/bjd.19551. Go to original source... Go to PubMed...
  37. El Hachem M, Zambruno G, Bourdon-Lanoy E, et al. Multi­centre consensus recommendations for skin care in inherited epidermolysis bullosa. Orphanet Journal of Rare Diseases [online]. 2014;9(1) [cit. 2022-08-27]. ISSN 1750-1172. Dostupné z: doi:10.1186/1750-1172-9-76. Go to original source... Go to PubMed...
  38. Lu Cy, Hsieh MS, Wei KC, et al. Gastrointestinal involvement of primary skin diseases. Journal of the European Academy of Dermatology and Venereology [online]. 2020; 34(12):2766-2774 [cit. 2022-10-12]. ISSN 0926-9959. Dostupné z: doi:10.1111/jdv.16676. Go to original source... Go to PubMed...
  39. Manjunath SR, Mahajan D, Handa S, et al. The severity of malnutrition in children with epidermolysis bullosa correlates with disease severity. Scientific Reports [online]. 2021;11(1) [cit. 2022-08-21]. ISSN 2045-2322. Dostupné z: doi:10.1038/s41598-021-96354. Go to original source... Go to PubMed...
  40. Tuncer S, Sezgin B, Kaya B, et al. An algorithmic approach for the management of hand deformities in dystrophic epidermolysis bullosa. Journal of Plastic Surgery and Hand Surgery [online]. 2017;52(2):80-86 [cit. 2022-10-09]. ISSN 2000. Dostupné z: doi:10.1080/2000656X.2017.1338183. Go to original source... Go to PubMed...
  41. Lembo F, Parisi D, Cecchino LR, et al. Release of pseudosyndactyly in recessive dystrophic epidermolysis bullosa using a dermal regeneration template glove: the Foggia experience. Orphanet Journal of Rare Diseases [online]. 2021; 16(1) [cit. 2022-10-09]. ISSN 1750-1172. Dostupné z: doi:10.1186/s13023-021-01697-5. Go to original source... Go to PubMed...
  42. Breitenbach J, Gruber Ch, Klausegger A, et al. Pseudosyndactyly - an inflammatory and fibrotic wound healing disorder in recessive dystrophic epidermolysis bullosa. JDDG: Journal der Deutschen Dermatologischen Gesellschaft [online]. 2015;13(12):1257-1266 [cit. 2022-08-21]. ISSN 16100379. Dostupné z: doi:10.1111/ddg.12839. Go to original source... Go to PubMed...
  43. Reimer A, Hess M, Schwieger-Briel A, et al. Natural history of growth and anaemia in children with epidermolysis bullosa: a retrospective cohort study*. British Journal of Dermatology [online]. 2020;182(6):1437-1448 [cit. 2022-08-21]. ISSN 0007-0963. Dostupné z: doi:10.1111/bjd.18475. Go to original source... Go to PubMed...
  44. Kaur J, Budhwar J, Maheshwary A, Bhatti KS. Blistering in a newborn: a rare case report. Int J Res Dermatol. 2020;6(3):432. doi: 10.18203/issn.2455-4529.IntJResDermatol20201596. Go to original source...




Dermatology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.